Cart summary

You have no items in your shopping cart.

    ANP32A Antibody

    Catalog Number: orb1239865

    DispatchUsually dispatched within 5-10 working days
    $ 574.00
    Catalog Numberorb1239865
    CategoryTools
    DescriptionANP32A Antibody
    Species/HostRabbit
    ClonalityPolyclonal
    Tested applicationsELISA, ICC, IF, WB
    IsotypeIgG
    ImmunogenAnti-PHAP I antibody (orb1239865) was raised against a peptide corresponding to 15 amino acids near the carboxy terminus of human PHAP I. The immunogen is located within the last 50 amino acids of PHAP I.
    Concentration1 mg/mL
    Dilution rangeWB: 2-4 μg/mL; ICC: 2 μg/mL; IF: 10 μg/mL.Antibody validated: Western Blot in human, mouse and rat samples; Immunocytochemistry in human samples; Immunofluorescence in human samples. All other applications and species not yet tested.
    Form/AppearanceLiquid
    ConjugationUnconjugated
    MWPredicted: 29kDObserved: 29 kD
    TargetANP32A
    UniProt IDP39687
    NCBIP39687
    StoragePHAP I antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
    Buffer/PreservativesPHAP I Antibody is supplied in PBS containing 0.02% sodium azide.
    Alternative namesPHAP I Antibody: LANP, MAPM, PP32, HPPCn, PHAP1, P
    Read more...
    NoteFor research use only
    Expiration Date12 months from date of receipt.
    ANP32A Antibody

    Western Blot Validation in Human Raji Cell Lysate. Loading: 15 µg of lysates per lane. Antibodies: PHAP I orb1239865 (A: 2 µg/mL, B: 4 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

    ANP32A Antibody

    Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines. Loading: 15 µg of lysates per lane. Antibodies: PHAP I orb1239865 (2 µg/mL), PHAP I orb1239868 (1 µg/mL), and beta-actin (1 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

    ANP32A Antibody

    Western Blot Validation in Human Cell Lines. Loading: 15 µg of lysates per lane. Antibodies: PHAP I orb1239865 (2 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

    ANP32A Antibody

    Immunofluorescence Validation of PHAP I in Raji Cells. Immunofluorescent analysis of 4% paraformaldehyde-fixed Raji Cells labeling PHAP I with orb1239865 at 10 µg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).

    ANP32A Antibody

    Immunocytochemistry Validation of PHAP I in Raji Cells. Immunocytochemical analysis of Raji cells using anti-PHAP I antibody (orb1239865) at 2 µg/ml. Cells was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

    ANP32A Antibody

    KD Validation of PHAPI in Human Breast Cancer Cells (Schafer et al., 2006). Human Breast Cancer Cells (T47D cells) were transfected with control or PHAPI siRNA duplex. PHAPI was detected via Western Blot analysis by using the anti-PHAPI antibody. PHAPI expression was reduced after PHAPI siRNA knockdown.

    ANP32A Antibody

    Increased Expression Validation of PHAPI in Patient Samples of BreastTumor Tissue (Schafer et al., 2006). PHAPI was overexpressed in all breast tumor samples of patients and human breast cancer cells (MDA-MB-453), but not in the normal breast tissue or human primary mammary epithelial cells (HMEC).

    ANP32A Antibody

    Overexpression of PHAPI in Breast Cancer Cells (Schafer et al., 2006). Western blot analysis with anti-PHAPI antibodies was performed for PHAPI in human cell lines from breast, prostate and lung. PHAPI was overexpressed in breast cancer cells when compared with normal cells (HMEC) whereas there were no significant differences in PHAPI expression in normal and cancer cells of either prostate or lung origin.

    ANP32A Antibody

    Induced Expression Validation of PHAPI/Anp32a in Atxn1 KO Mice (Sa´nchez et al., 2013). Western blot analysis of PHAPI/Anp32a from the cerebellum of WT and Atxn1 KO mice. PHAPI expression was significantly increased (2 folds) in Atxn1 KO mice as compared to WT mice. The same effect was observed in PHAPI mRNA levels.

    • ANP32A antibody [orb178621]

      IHC,  WB

      Human, Mouse, Rat

      Polyclonal

      Unconjugated

      50 μl, 100 μl, 200 μl
    • ANP32A Antibody [orb1239868]

      ELISA,  IF,  IHC-P,  WB

      0.1 mg, 0.02 mg
    • ANP32A antibody [orb352982]

      ELISA,  IF,  IHC

      Human

      Rabbit

      Polyclonal

      Unconjugated

      100 μl, 50 μl
    • ANP32A Antibody [orb1239245]

      ELISA,  IF,  IHC-P,  WB

      0.1 mg, 0.02 mg
    • ANP32A Antibody [orb1242254]

      ELISA,  IHC,  WB

      Human

      Rabbit

      Polyclonal

      Unconjugated

      100 μl
    Submit a review

    Filter by Rating

      • Star
      • Star
      • Star
      • Star
      • Star
      • 5 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 4 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 3 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 2 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 1 stars